Function
Proteasome (PRTS) are large protein complexes which degrade unneeded proteins into small polypeptides[1]. The 26S PRTS is composed of a central 20S core particle which contains 4 stacked rings each with several members and two 19S caps. The 19S cap is composed of a base with 10 proteins six of which are ATPases and a lid which contains 9 proteins which bind polyubiquitin.
- 13S PRTS is a PRTS core intermediate containing α ring, partial β ring and 3 chaperones[2].
- 15S PRTS is half of an 20S PRTS and upon dimerisation forms the mature 20S PRTS[3].
- 19S PRTS is the regulatory paricle pf PRTS which recognizes the ubiquinated substrates destined for proteolysis[4].
- Immunoproteasome is PRTS variant induced by inflammation[5].
- Preholoproteasome is created by the fusion of 2 half 20S particles yielding an immature PRTS[6].
- 20S PRTS Pre1-1 mutation is yeast PRTS variant which prevents PRTS maturation.
For more details see 3unb.
Structural highlights
The core particle two outer rings contain 7 α subunits (Y7, Y13, PRE6, PRE5, PUP2, C1, C7-α) which form the PRTS gate. The two inner rings contain 7 β subunits (PRE2, PRE4, PRE3, PUP1, PUP3, C5, C11) with protease activity[7].
3D Structures of Proteasome
Proteasome 3D structures
See Also
PROTAC (Proteolysis-Targeting Chimera), an alternative to conventional enzyme inhibitors, by enabling proteasome induced degradation of the target protein.
- ↑ Saeki Y, Tanaka K. Assembly and function of the proteasome. Methods Mol Biol. 2012;832:315-37. doi: 10.1007/978-1-61779-474-2_22. PMID:22350895 doi:https://dx.doi.org/10.1007/978-1-61779-474-2_22
- ↑ Schnell HM, Walsh RM Jr, Rawson S, Kaur M, Bhanu MK, Tian G, Prado MA, Guerra-Moreno A, Paulo JA, Gygi SP, Roelofs J, Finley D, Hanna J. Structures of chaperone-associated assembly intermediates reveal coordinated mechanisms of proteasome biogenesis. Nat Struct Mol Biol. 2021 May;28(5):418-425. PMID:33846632 doi:10.1038/s41594-021-00583-9
- ↑ Tundo GR, Sbardella D, Santoro AM, Coletta A, Oddone F, Grasso G, Milardi D, Lacal PM, Marini S, Purrello R, Graziani G, Coletta M. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges. Pharmacol Ther. 2020 Sep;213:107579. PMID:32442437 doi:10.1016/j.pharmthera.2020.107579
- ↑ Ehlinger A, Walters KJ. Structural insights into proteasome activation by the 19S regulatory particle. Biochemistry. 2013 May 28;52(21):3618-28. PMID:23672618 doi:10.1021/bi400417a
- ↑ Ferrington DA, Gregerson DS. Immunoproteasomes: structure, function, and antigen presentation. Prog Mol Biol Transl Sci. 2012;109:75-112. doi: , 10.1016/B978-0-12-397863-9.00003-1. PMID:22727420 doi:https://dx.doi.org/10.1016/B978-0-12-397863-9.00003-1
- ↑ Walsh RM Jr, Rawson S, Schnell HM, Velez B, Rajakumar T, Hanna J. Structure of the preholoproteasome reveals late steps in proteasome core particle biogenesis. Nat Struct Mol Biol. 2023 Oct;30(10):1516-1524. PMID:37653242 doi:10.1038/s41594-023-01081-w
- ↑ Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996;65:801-47. PMID:8811196 doi:https://dx.doi.org/10.1146/annurev.bi.65.070196.004101